• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 May;28(5):1026-1030.
doi: 10.3201/eid2805.211951.
SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

Wendelin Moser, Mohammed Ahmed Hassan Fahal, Elamin Abualas, Shahinaz Bedri, Mahgoub Taj Elsir, Mona Fateh El Rahman Omer Mohamed, Abdelhalim Babiker Mahmoud, Amna Ismail Ibrahim Ahmad, Mohammed A Adam, Sami Altalib, Ola Adil DafaAllah, Salahaldin Abdallah Hmed, Andrew S Azman, Iza Ciglenecki, Etienne Gignoux, Alan González, Christine Mwongera, Manuel Albela Miranda

Abstract

In a cross-sectional survey in Omdurman, Sudan, during March-April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.

Keywords: Abualas E; Bedri S; COVID-19; Elsir MT; Fahal MAH; Mohamed MFERO; Omdurman; SARS-CoV-2; Sudan; Sudan. Emerg Infect Dis. 2022 May [date cited]. https://doi.org/10.3201/eid2805.211951; Suggested citation for this article: Moser W; antibody; et al. SARS-CoV-2 antibody prevalence and population-based death rates; excess mortality; greater Omdurman; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom